Company profile for Sapu Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sapu Bioscience is an immuno-oncology company dedicated to the development of first-in-class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Sapu Bioscience, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single-agent activity in relapsed/refractory cancer patients in clinical trial settings. Sapu Bioscience is seeking to...
Sapu Bioscience is an immuno-oncology company dedicated to the development of first-in-class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Sapu Bioscience, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single-agent activity in relapsed/refractory cancer patients in clinical trial settings. Sapu Bioscience is seeking to leverage its deep expertise in drug development to improve treatment outcomes and the survival of cancer patients with a special emphasis on rare pediatric cancers.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
29397 Agoura Road, Suite 107 Agoura Hills, CA 91301
Telephone
Telephone
+1 6506357018
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/11/3185378/0/en/Oncotelic-Therapeutics-and-Sapu-Bioscience-Announce-Publication-on-Sub-15-nm-Nanoparticles-in-International-Journal-of-Molecular-Sciences.html

GLOBENEWSWIRE
11 Nov 2025

https://www.globenewswire.com/news-release/2025/07/18/3117701/0/en/SAPU-Bioscience-Highlights-Peer-Reviewed-Publication-Linking-TGFB2-to-Survival-in-Younger-Pancreatic-Cancer-Patients.html

GLOBENEWSWIRE
17 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty